These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 36992765)
1. Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey. Huhndt A; Chen Y; O'Donnell S; Cooper D; Ballhausen H; Gajewska KA; Froment T; Wäldchen M; Lewis DM; Raile K; Skinner TC; Braune K Front Clin Diabetes Healthc; 2022; 3():876511. PubMed ID: 36992765 [TBL] [Abstract][Full Text] [Related]
2. Barriers to uptake of Open-Source automated insulin delivery Systems: Analysis of socioeconomic factors and perceived challenges of adults with type 1 diabetes from the OPEN survey. O'Donnell S; Cooper D; Chen Y; Ballhausen H; Lewis DM; Froment T; Anna Gajewska K; Tappe A; Skinner T; Cleal B; Braune K Diabetes Res Clin Pract; 2023 Mar; 197():110235. PubMed ID: 36581143 [TBL] [Abstract][Full Text] [Related]
3. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey. Braune K; Gajewska KA; Thieffry A; Lewis DM; Froment T; O'Donnell S; Speight J; Hendrieckx C; Schipp J; Skinner T; Langstrup H; Tappe A; Raile K; Cleal B J Med Internet Res; 2021 Jun; 23(6):e25409. PubMed ID: 34096874 [TBL] [Abstract][Full Text] [Related]
4. Emotional and Physical Health Impact in Children and Adolescents and Their Caregivers Using Open-source Automated Insulin Delivery: Qualitative Analysis of Lived Experiences. Braune K; Krug N; Knoll C; Ballhausen H; Thieffry A; Chen Y; O'Donnell S; Raile K; Cleal B J Med Internet Res; 2022 Jul; 24(7):e37120. PubMed ID: 35834298 [TBL] [Abstract][Full Text] [Related]
5. Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes. Lewis DM; Hussain S Diabetes Ther; 2022 Sep; 13(9):1683-1699. PubMed ID: 35913655 [TBL] [Abstract][Full Text] [Related]
6. Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children's Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems. Crabtree TSJ; Choudhary P; Lumb A; Hammond P; McLay A; Campbell F; Ng SM; Wilmot EG; Hussain S Diabetes Ther; 2022 Feb; 13(2):341-353. PubMed ID: 35099784 [TBL] [Abstract][Full Text] [Related]
7. Quality of life and psychological well-being among children and adolescents with diabetes and their caregivers using open-source automated insulin delivery systems: Findings from a multinational survey. Knoll C; Schipp J; O'Donnell S; Wäldchen M; Ballhausen H; Cleal B; Gajewska KA; Raile K; Skinner T; Braune K Diabetes Res Clin Pract; 2023 Feb; 196():110153. PubMed ID: 36423699 [TBL] [Abstract][Full Text] [Related]
8. Open-source Web Portal for Managing Self-reported Data and Real-world Data Donation in Diabetes Research: Platform Feasibility Study. Cooper D; Ubben T; Knoll C; Ballhausen H; O'Donnell S; Braune K; Lewis D JMIR Diabetes; 2022 Mar; 7(1):e33213. PubMed ID: 35357312 [TBL] [Abstract][Full Text] [Related]
9. Psychosocial Outcomes Among Users and Nonusers of Open-Source Automated Insulin Delivery Systems: Multinational Survey of Adults With Type 1 Diabetes. Schipp J; Hendrieckx C; Braune K; Knoll C; O'Donnell S; Ballhausen H; Cleal B; Wäldchen M; Lewis DM; Gajewska KA; Skinner TC; Speight J J Med Internet Res; 2023 Dec; 25():e44002. PubMed ID: 38096018 [TBL] [Abstract][Full Text] [Related]
10. Digital technologies as sources of information for patients and caregivers during COVID-19 pandemic: A cross-sectional survey. Hassan AYI; Bronzini M; Lamura G Digit Health; 2023; 9():20552076231156214. PubMed ID: 36908378 [TBL] [Abstract][Full Text] [Related]
11. Interviews with Indigenous Māori with type 1 diabetes using open-source automated insulin delivery in the CREATE randomised trial. Burnside M; Haitana T; Crocket H; Lewis D; Meier R; Sanders O; Jefferies C; Faherty A; Paul R; Lever C; Price S; Frewen C; Jones S; Gunn T; Wheeler BJ; Pitama S; de Bock M; Lacey C J Diabetes Metab Disord; 2023 Jun; 22(1):861-871. PubMed ID: 37250371 [TBL] [Abstract][Full Text] [Related]
12. Learning challenges of healthcare professionals supporting open-source automated insulin delivery. Crocket H; Lewis DM; Burnside M; Faherty A; Wheeler B; Frewen C; Lever C; Jefferies C; Williman J; Sanders O; Wilson R; Paul R; Price S; Jones S; de Bock M Diabet Med; 2022 May; 39(5):e14750. PubMed ID: 34826158 [TBL] [Abstract][Full Text] [Related]
13. [Position paper: Open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : Technology Committee of the Austrian Diabetes Association]. Kietaibl AT; Schütz-Fuhrmann I; Bozkurt L; Frühwald L; Rami-Merhar B; Fröhlich-Reiterer E; Hofer SE; Tauschmann M; Resl M; Hörtenhuber T; Stechemesser L; Winhofer Y; Riedl M; Zlamal-Fortunat S; Eichner M; Stingl H; Schelkshorn C; Weitgasser R; Rega-Kaun G; Köhler G; Mader JK Wien Klin Wochenschr; 2024 Jul; 136(Suppl 9):467-477. PubMed ID: 39196351 [TBL] [Abstract][Full Text] [Related]
14. The Do-It-Yourself Artificial Pancreas: A Comprehensive Review. Kesavadev J; Srinivasan S; Saboo B; Krishna B M; Krishnan G Diabetes Ther; 2020 Jun; 11(6):1217-1235. PubMed ID: 32356245 [TBL] [Abstract][Full Text] [Related]
15. Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Children and Adolescents With Type 1 Diabetes: Online Survey and Analysis of Self-Reported Clinical Outcomes. Braune K; O'Donnell S; Cleal B; Lewis D; Tappe A; Willaing I; Hauck B; Raile K JMIR Mhealth Uhealth; 2019 Jul; 7(7):e14087. PubMed ID: 31364599 [TBL] [Abstract][Full Text] [Related]
16. Evidence on User-Led Innovation in Diabetes Technology (The OPEN Project): Protocol for a Mixed Methods Study. O'Donnell S; Lewis D; Marchante Fernández M; Wäldchen M; Cleal B; Skinner T; Raile K; Tappe A; Ubben T; Willaing I; Hauck B; Wolf S; Braune K JMIR Res Protoc; 2019 Nov; 8(11):e15368. PubMed ID: 31742563 [TBL] [Abstract][Full Text] [Related]
17. Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes. MacLeish SA; Hood KK; Polonsky WH; Wood JR; Bode BW; Forlenza GP; Laffel LM; Buckingham BA; Criego AB; Schoelwer MJ; DeSalvo DJ; Sherr JL; Hansen DW; Conroy LR; Huyett LM; Vienneau TE; Ly TT; Diabetes Obes Metab; 2024 Dec; 26(12):5569-5579. PubMed ID: 39300963 [TBL] [Abstract][Full Text] [Related]
18. CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes. Burnside M; Lewis D; Crocket H; Wilson R; Williman J; Jefferies C; Paul R; Wheeler BJ; de Bock M J Diabetes Metab Disord; 2020 Dec; 19(2):1615-1629. PubMed ID: 32837953 [TBL] [Abstract][Full Text] [Related]
19. Large-Scale Data Analysis for Glucose Variability Outcomes with Open-Source Automated Insulin Delivery Systems. Shahid A; Lewis DM Nutrients; 2022 May; 14(9):. PubMed ID: 35565875 [TBL] [Abstract][Full Text] [Related]
20. Do-It-Yourself Artificial Pancreas Systems in Type 1 Diabetes: Perspectives of Two Adult Users, a Caregiver and Three Physicians. Marshall DC; Holloway M; Korer M; Woodman J; Brackenridge A; Hussain S Diabetes Ther; 2019 Oct; 10(5):1553-1564. PubMed ID: 31440989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]